Status:

UNKNOWN

Auxiliary Diagnosis of Liver Nodules Using cfDNA Whole-genome Signatures

Lead Sponsor:

The Second Affiliated Hospital of Chongqing Medical University

Collaborating Sponsors:

Eastern Hepatobiliary Surgery Hospital

Nanfang Hospital, Southern Medical University

Conditions:

Focal Liver Lesions

Eligibility:

All Genders

18+ years

Brief Summary

As a prospective, multi-center study, GUIDER will recruit 400 liver nodules participants from different provinces and regions across China. Except for cfDNA signatures, serum biomarkers, histopatholog...

Detailed Description

Patients with liver nodules will be recruited for 1 year. Peripheral blood samples of all participants will be collected after being informed about the study and potential risks. CfDNA extraction, lib...

Eligibility Criteria

Inclusion

  • Eighteen years or elder;
  • Participants underwent enhanced MRI for the evaluation of liver nodules ≤5 cm;
  • Participants whose platelet count ≥ 50×109/L, prothrombin activity (PTA) ≥ 60%;
  • Participants who are willing and able to perform hepatectomy or tissure biopsy.

Exclusion

  • Participants with different enhancement mode liver nodules that detected by enhanced MRI and without CEUS confirmation;
  • Diagnosis of malignant tumors before recruitment;
  • Anti-tumor therapy before recruitment ;
  • HIV infection;
  • Pregnancy;
  • Allogenic blood transfusion or cell therapy within 14 days before peripheral blood samples collection;
  • Participants with hepatic encephalopathy, hemangioma, ascites, gastrointestinal bleeding, jaundice, liver failure, congestive heart failure, or any other serious diseases that causing organ damage.
  • Participants with any other factors that may leading to termination of the study.

Key Trial Info

Start Date :

May 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

October 1 2023

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT05393102

Start Date

May 1 2022

End Date

October 1 2023

Last Update

May 26 2022

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

The 2nd affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China, 400010

2

Nanfang Hospital, Southern Medical University

Guangzhou, Guangdong, China, 510515

3

Eastern Hepatobiliary Surgery Hospital

Shanghai, Shanghai Municipality, China, 200438

Auxiliary Diagnosis of Liver Nodules Using cfDNA Whole-genome Signatures | DecenTrialz